2022年7月20日 · All neuroendocrine tumors: According to the Surveillance Epidemiology and Ends Results (SEER) database, the five-year survival rate for all neuroendocrine tumors is 39.4 percent.

The 5-year survival rate for stage 2 NETs can be promising at around 90%, especially with multidisciplinary treatment approaches. While survival rates may be lower, some patients can still achieve long-term remission and improved quality of life with treatment.

The survival rate for patients with neuroendocrine tumors can be quite favorable, especially when diagnosed and treated while in an early stage.

2024年1月16日 · Understanding the survival rate of neuroendocrine tumors depends on the type of tumor, its growth rate, location, and stage of cancer. Here’s what you should know.

Observed survival is the percentage of people with a particular cancer who are alive at a certain point in time after their diagnosis. For example, a 5-year observed survival of 70% means that, on average, people have a 7 in 10 chance of being alive 5 years after their diagnosis.

The SEER database tracks 5-year relative survival rates for pancreatic NET in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages (stage 1, stage 2, stage 3, etc.).

If you have a neuroendocrine tumour (NET), you may have questions about your prognosis. A prognosis is the doctor’s best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors.

2021年3月18日 · What is the survival rate of NETs? The median overall survival (OS) time for all patients has been 9.3 years (112 months). Localized NETs (without any spread), which had been successfully resected, had better median OS (>30 years). Survival is less in patients in whom tumours had spread.